Moderate-to-Severe Eczema for Adults
Enrollment Opens: 03-21-2022
Enrollment Closes: TBD
This study tests an investigational medication for the treatment of moderate-to-severe atopic dermatitis. Participants must have previously tried topical treatments and either they haven’t worked or they are unable to use them.
Study ID: OMRC-000138
To Enroll: Visit http://www.oregonmedicalresearch.com to learn more and fill out the contact form, or call 503-245-1525 to contact us directly.
Posted by: Oregon Medical Research Center | http://www.oregonmedicalresearch.com